Cellectis S.A Return on Equity (ROE) Growth & History (CLLS)
Cellectis S.A's return on equity was −65.33% for fiscal 2025.
View full Cellectis S.A company overviewCellectis S.A annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −65.33% | −31.25 pp |
| 2024 | 2024-12-31 | −34.08% | +72.94 pp |
| 2023 | 2023-12-31 | −107.02% | −39.79 pp |
| 2022 | 2022-12-31 | −67.22% | −17.69 pp |
| 2021 | 2021-12-31 | −49.54% | −16.99 pp |
| 2020 | 2020-12-31 | −32.55% | −0.75 pp |
| 2019 | 2019-12-31 | −31.81% | −5.60 pp |
| 2018 | 2018-12-31 | −26.20% | +12.36 pp |
| 2017 | 2017-12-31 | −38.57% | −14.51 pp |
| 2016 | 2016-12-31 | −24.06% | −11.50 pp |
| 2015 | 2015-12-31 | −12.56% | — |
Cellectis S.A quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −43.21% | −22.40 pp |
| Q1 2026 | 2026-03-31 | −26.16% | — |
| Q4 2025 | 2025-12-31 | −29.84% | — |
| Q3 2025 | 2025-09-30 | 0.60% | — |
| Q2 2025 | 2025-06-30 | −20.81% | +0.85 pp |
| Q2 2024 | 2024-06-30 | −21.66% | −6.15 pp |
| Q2 2023 | 2023-06-30 | −15.51% | −5.54 pp |
| Q2 2022 | 2022-06-30 | −9.97% | +4.90 pp |
| Q2 2021 | 2021-06-30 | −14.87% | −3.36 pp |
| Q2 2020 | 2020-06-30 | −11.51% | — |
Cellectis S.A return on equity trends
Over the last five fiscal years, Cellectis S.A's return on equity decreased from −32.55% to −65.33%, a change of −32.78 percentage points. The latest reported quarter, Q2 2026, shows −43.21%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cellectis S.A source filings ↗